News

Investment Insights: Understanding Nike's Options Trends

Investment Insights: Understanding Nike's Options Trends

Recent Trends in Nike Options Trading

Lately, major investors have taken a bearish stance toward Nike (NKE). This change in sentiment is important for retail investors trying to navigate the shifting landscape of options trading.

We’ve observed some unusual trading activity in Nike options that hints at possible future market movements. These trends often suggest that large investors either have insider knowledge or are reacting to expected market changes.

Our options scanner has picked up a series of significant trades linked to Nike, revealing a notable pattern among investors. Their attitudes seem to fluctuate between bullish excitement and bearish caution.

Insights into Major Options Trades

A closer look shows that around 25% of these trades indicate a bullish outlook, while about 50% display a bearish sentiment. In our analysis, we identified three put options worth a total of $330,474, compared to five call options totaling $349,385.

Projected Price Movements

Given the volume and open interest of these options contracts, it looks like institutional investors—often called whales—are eyeing a price range of $70.00 to $90.00 over the last three months. Knowing these target ranges can help retail traders fine-tune their investment strategies.

Understanding Volume and Open Interest Metrics

By closely examining volume and open interest, options traders can gain valuable insights. These two metrics are essential for assessing liquidity and gauging overall interest in Nike options at specific strike prices.

Recent Trends in Nike Options Volume

New data sheds light on the changes in volume and open interest for both puts and calls, aligning with significant trades in the mentioned strike price range.

Key Options Trades Observed Recently

We’ve tracked notable trades characterized by varying sentiments:

  • Symbol: NKE, PUT/CALL: PUT, Trade Type: Trade, Sentiment: Neutral, Exp. Date: 09/19/25, Price: $4.53, Total Trade Value: $271.8K
  • Symbol: NKE, PUT/CALL: CALL, Trade Type: Trade, Sentiment: Bearish, Exp. Date: 11/01/24, Price: $1.36, Total Trade Value: $122.4K
  • Symbol: NKE, PUT/CALL: CALL, Trade Type: Trade, Sentiment: Bearish, Exp. Date: 10/25/24, Price: $4.70, Total Trade Value: $94.0K
  • Symbol: NKE, PUT/CALL: CALL, Trade Type: Trade, Sentiment: Neutral, Exp. Date: 10/04/24, Price: $3.25, Total Trade Value: $48.7K
  • Symbol: NKE, PUT/CALL: CALL, Trade Type: Sweep, Sentiment: Bearish, Exp. Date: 11/15/24, Price: $4.10, Total Trade Value: $42.6K

About Nike

Nike is the leading brand in athletic footwear and apparel worldwide, boasting a diverse portfolio that includes basketball, running, and soccer products. Footwear alone accounts for roughly two-thirds of their total sales. Iconic brands like Nike, Jordan, and Converse offer a broad range of athletic and casual options.

With a global presence, Nike sells its products through both company-owned and franchised stores as well as various third-party retailers. Their e-commerce platforms extend across more than 40 countries, significantly expanding their market reach. To support their production needs, they rely on contract manufacturers in over 30 countries.

Let’s now examine the market dynamics currently impacting Nike's performance.

Current Performance Overview for Nike

  • The stock is trading at $81.07, up slightly by 0.53%, with a trading volume of 2,887,055.
  • Indicators show that the Relative Strength Index (RSI) is neutral, suggesting a balance between overbought and oversold conditions.
  • An earnings announcement is coming soon, adding more interest around the stock's movement.

What Analysts Are Saying About Nike

In the past month, three analysts have assessed Nike’s stock, with an average price target set at $81.00. Their opinions differ, providing a broad view of what lies ahead:

  • Barclays keeps an Equal-Weight rating, projecting a price target of $84.
  • Piper Sandler has downgraded their rating to Neutral, maintaining a price target of $80.
  • Stifel continues to hold a Hold rating, with a target of $79.

Engaging in options trading can be risky, but it also offers opportunities for significant profits. Traders who are informed and strategic can minimize risks by staying educated and aware of market changes. To succeed in the options market, it’s vital to monitor Nike's options trades and evolving market trends closely.

Frequently Asked Questions

What does recent trading data suggest about Nike's stock?

Recent trading data indicates a divided sentiment among large investors, with both bullish and bearish positions evident, especially in options trading.

What price range are investors targeting for Nike?

Investors are focusing on a price range of $70.00 to $90.00 for Nike over the past few months, signaling significant support and resistance levels.

How are analysts rating Nike's stock currently?

Analysts have varying ratings with price targets from $79 to $84, reflecting different expectations for its future performance.

Why is understanding options trading important?

Options trading can offer potential profits but also involves higher risks; grasping market dynamics helps investors make better-informed decisions.

How can I stay updated on Nike's options trades?

Using dedicated financial platforms, like options scanners, can help track important trades and gauge market sentiment surrounding Nike.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 175

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 127

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 59

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 227

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 291

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 87

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 118

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 10

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 231

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 0

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading

Top 5 Most Recently Viewed Articles

NEXE Innovations Unveils Impressive Q3 Financial Performance

Updated Category News Views 289

NEXE Innovations Reports Record Financial Growth WINDSOR, Ontario -- NEXE Innovations Inc. (TSX.V: NEXE) (Frankfurt: NX5) (OTC: NEXNF), a leading player in compostable materials, is excited to share its financial results for the three-month period concluding on February 28, 2025. Showcasing its growth and robust strategies, NEXE has marked significant milestones,...

Continue Reading
Insights into Globus Medical's Upcoming Earnings Report

Updated Category News Views 179

Anticipation for Globus Medical's Earnings Report Globus Medical (NYSE: GMED) is preparing to unveil its quarterly earnings report soon. Investors are eager to discover the outcomes that could influence their investment decisions, and this report is no exception. With increasing excitement surrounding the earnings announcement, analysts project earnings per share (EPS) to...

Continue Reading
Celebrating Green Leaders: 2024 IGIHOF Induction Ceremony Details

Updated Category News Views 278

Celebrating the Newest Inductees into the Green Industry The International Green Industry Hall of Fame (IGIHOF) is gearing up for its annual induction ceremony, where it will honor nine remarkable individuals and organizations dedicated to advancing ecological sustainability. This year, the event will take place within the environment of innovative learning at the...

Continue Reading
Royce Micro-Cap Trust Announces Q4 Distribution Details

Updated Category News Views 176

Royce Micro-Cap Trust Announces Fourth Quarter Distribution Royce Micro-Cap Trust, Inc. (NYSE-RMT) has proudly declared a significant fourth quarter distribution, amounting to $0.24 per share on its Common Stock. This distribution not only underscores the Trust's commitment to its shareholders but also allows them the option to receive the payout in cash or as additional...

Continue Reading
Cellectis Showcases Innovations in Non-Viral Gene Therapy at Congress

Updated Category News Views 214

Exciting Advances in Gene Therapy by Cellectis Cellectis, a clinical-stage biotechnology company, is making headlines with its innovative approach to gene therapy, particularly in the exciting world of gene editing. Recently, the company announced significant findings regarding the potential of circular single-stranded DNA (CssDNA) as a universal non-viral template for...

Continue Reading